ACCESSWIRE
10 May 2022, 06:25 GMT+10
Live Video Webcast Event with Russ Trenary, President and CEO of Outlook Therapeutics on Wednesday, May 11th at 1:00 PM ET
FRENCHTOWN, NJ / ACCESSWIRE / May 9, 2022 / JTC Team ('JTC'), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor CEO Spotlight Event Featuring Outlook Therapeutics on Wednesday, May 11, 2022 at 1:00 PM ET. Access the event here.
Outlook Therapeutics is a pre-commercial biopharmaceutical company working to develop and launch ONS-5010/ LYTENAVA™ (bevacizumab-vikg), an investigational therapy, as the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, including wet AMD, DME and BRVO. Outlook Therapeutics has submitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ONS-5010 to treat wet AMD. The submission is supported by Outlook Therapeutics' wet AMD registration clinical program, which consists of three clinical trials: NORSE ONE, NORSE TWO, and NORSE THREE. If ONS-5010 ophthalmic bevacizumab is approved, Outlook Therapeutics expects to commercialize it as the first and only FDA-approved ophthalmic formulation of bevacizumab for use in treating retinal diseases in the United States, United Kingdom, Europe, Japan and other markets.
A live video webcast of the Spotlight event will be available on www.virtualinvestorco.com. A webcast replay will be made available shortly after the conclusion of the live event and will be accessible for 90 days.
About JTC Team
JTC is a fully integrated corporate communications firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit www.jtcir.com or connect with the company on Twitter and LinkedIn.
CONTACT:
Jenene Thomas
JTC Team, LLC
T: +1 (833) 475-8247
jtc@jtcir.com
SOURCE: JTC Team, LLC
Get a daily dose of Memphis Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Memphis Sun.
More InformationHONG KONG: An engineering vessel with 30 people on board went missing 200 miles off Hong Kong after it snapped ...
NICE, France -As some 1,000 Frenchmen are being hospitalized daily with Covid infections, French officials have "invited" or "recommended" the ...
BRUSSELS, Belgium: Negotiations on a free trade agreement between the European Union and New Zealand ended successfully this week, paving ...
CAIRO, Egypt: Egyptian authorities have prohibited swimming in a stretch of the Red Sea after an Australian woman was killed ...
NEW YORK CITY, New York: Bette Nash, age 86, has been named the longest serving flight attendant in the world, ...
LONDON, England: A UK parliamentary committee has told lawmakers that they may not bring babies to parliamentary proceedings and debates.The ...
SAN FRANCISCO, California: In response to a string of shootings that have broken out at U.S. properties it lists, rental ...
SYDNEY, NSW, Australia - Stocks in Asia strengthened on Tuesday with major gains recorded across the region.The Reserve Bank of ...
NEW DELHI, India: As the Indian government aims to increase local fuel supplies to meet rising demand and boost federal ...
HOUSTON, Texas: Exxon Mobil Corp said this week that profits from skyrocketing fuel prices could result in a record $16 ...
BEIJING, China: Chinese airlines announced last week that they would purchase some 300 Airbus jets. This is the largest order ...
SYDNEY, NSW, Australia - Stocks in Asia generally moved higher on Monday despite continuing concerns over a potential global recession. ...